Convert Newton NEWT to Transfidelity FIDEL

What Is Newton Protocol (NEWT)? Newton Protocol is the decentralized policy layer that makes onchain compliance verifiable, programmable, and automatic. Builders define how digital assets can move by setting rules that check every transaction for things like sanctions, identity, or risk before it goes through. By turning compliance into code, Newton Protocol replaces manual reviews with real-time, upgradeable enforcement. Financial institutions, stablecoin issuers, RWA platforms, and AI agents can now meet evolving regulatory requirements directly at the point of transaction without giving up transparency, privacy, or decentralization. Builder defined rules, called policies, use both onchain and offchain data to decide whether a transaction should be approved or blocked. A decentralized network of operators, secured through Ethereum restaking and NEWT, evaluates each policy inside Trusted Execution Environments (TEEs) and generates proofs to show the checks were done correctly. The results can be verified by anyone through the Newton Explorer. NEWT is the native utility token and is used for: *Fees for compliance compute. *Rewards for network operators and delegated staking. *Governance votes that shape the protocol. Who Are the Founders of Newton Protocol? Newton Protocol is the vision of Magic Labs and its co-founders Sean Li and Jaemin Jin. Magic Labs created the first embedded wallet in the crypto industry, helping 200K+ developers create 50M+ wallets to get onchain with trailblazing customers such as Polymarket, Forbes, Helium, WalletConnect, Mattel, and Naver. The Magic Newton Foundation is responsible for driving adoption, enabling open development and supporting decentralization of the Newton Protocol. Management of the Magic Newton Foundation is led by an independent board of directors. What Makes Newton Protocol Unique? Newton Protocol introduces compliance-as-code, a way to make rules verifiable and enforceable directly onchain. Just as smart contracts made execution programmable and oracles made data composable, Newton Protocol makes compliance itself part of the transaction process. Its policy layer, operator network, and oracle adapters work together to check every transaction against defined rules, producing cryptographic proofs that confirm those checks were done correctly. Builders can write and update policies in familiar languages like Rego, while decentralized operators evaluate them and verify results in real time. Because Newton Protocol is fully composable, any dapp, stablecoin, or AI wallet can integrate its policy client to enforce business or regulatory rules automatically, creating a neutral, decentralized compliance layer that connects institutions, regulators, and autonomous agents through verifiable trust.

Neurodegenerative diseases such as Alzheimer's Disease are devastating conditions that impact millions globally. These diseases are driven by the misfolding and aggregation of proteins, which lead to brain cell death and cognitive decline. To make matters worse, as we age our cells become more error-prone, resulting in more errors during protein printing, causing proteins to clump together and form aggregates. Project Transfidelity aims to solve this by improving the accuracy of protein printing, preventing toxic aggregates from forming. Led by Dr. Dimitri Scherbakov and Dr. Rashid Akbergenov, with over 50 years of combined experience in the lab, we have identified two molecules that may improve the efficiency of protein production, potentially preventing protein aggregates, hypothesized to cause dementia. Despite the significant research funding allocated to neurodegenerative diseases, current therapies continue to treat the symptoms caused by the protein aggregates, with little progress made to stop or reverse disease. We’re trying to go after a potential root cause - rather than trying to clear aggregates once they are there, we aim to prevent them from forming in the first place by reducing the production of faulty proteins. With a clear path towards developing novel intellectual property (IP) and an ever-growing target market, we believe we are poised to make an impact on neurodegenerative disorders and the way we age.